Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Assembly Biosciences (ASMB) over the last 16 years, with Dec 2024 value amounting to -$13.3 million.

  • Assembly Biosciences' Other Working Capital Changes fell 44.30% to -$9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.1 million, marking a year-over-year decrease of 132.33%. This contributed to the annual value of -$13.3 million for FY2024, which is 115.91% down from last year.
  • Assembly Biosciences' Other Working Capital Changes amounted to -$13.3 million in FY2024, which was down 115.91% from $83.6 million recorded in FY2023.
  • Over the past 5 years, Assembly Biosciences' Other Working Capital Changes peaked at $83.6 million during FY2023, and registered a low of -$28.1 million during FY2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$3.7 million (2022), whereas its average is $22.2 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 1,122,540.00% in 2020, then surged by 2,376.87% in 2023.
  • Assembly Biosciences' Other Working Capital Changes (Yearly) stood at -$28.1 million in 2020, then surged by 77.71% to -$6.3 million in 2021, then soared by 41.32% to -$3.7 million in 2022, then surged by 2,376.87% to $83.6 million in 2023, then tumbled by 115.91% to -$13.3 million in 2024.